High-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 4, Pages 952
Publisher
MDPI AG
Online
2019-02-22
DOI
10.3390/ijms20040952
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers
- (2018) Yuxuan Wang et al. Science Translational Medicine
- Comparison of Clinical Features and Outcomes in Epithelial Ovarian Cancer according to Tumorigenicity in Patient-Derived Xenograft Models
- (2018) Kyung Jin Eoh et al. Cancer Research and Treatment
- High-grade serous carcinomas arise in the mouse oviduct via defects linked to the human disease
- (2017) Yali Zhai et al. JOURNAL OF PATHOLOGY
- Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Robert L Coleman et al. LANCET
- Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
- (2017) Eric Pujade-Lauraine et al. LANCET ONCOLOGY
- Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
- (2017) Catherine M Phelan et al. NATURE GENETICS
- Haploinsufficiency networks identify targetable patterns of allelic deficiency in low mutation ovarian cancer
- (2017) Joe Ryan Delaney et al. Nature Communications
- The Prognostic 97 Chemoresponse Gene Signature in Ovarian Cancer
- (2017) Abel Matondo et al. Scientific Reports
- Establishment of a Novel Histopathological Classification of High-Grade Serous Ovarian Carcinoma Correlated with Prognostically Distinct Gene Expression Subtypes
- (2016) Ryusuke Murakami et al. AMERICAN JOURNAL OF PATHOLOGY
- The Dualistic Model of Ovarian Carcinogenesis
- (2016) Robert J. Kurman et al. AMERICAN JOURNAL OF PATHOLOGY
- Patient-reported outcomes in GOG 252: NRG Oncology Study of IV vs IP chemotherapy for ovarian, fallopian, or peritoneal carcinoma
- (2016) J.L. Walker et al. GYNECOLOGIC ONCOLOGY
- A phase III trial of bevacizumab with IV versus IP chemotherapy for ovarian, fallopian tube, and peritoneal carcinoma: An NRG Oncology Study
- (2016) J. Walker et al. GYNECOLOGIC ONCOLOGY
- Molecular Alterations of TP53 are a Defining Feature of Ovarian High-Grade Serous Carcinoma
- (2016) Russell Vang et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium
- (2016) Nicolas Wentzensen et al. JOURNAL OF CLINICAL ONCOLOGY
- In vitroandin vivocorrelates of physiological and neoplastic human Fallopian tube stem cells
- (2016) Yusuke Yamamoto et al. JOURNAL OF PATHOLOGY
- Update on Poly-ADP-ribose polymerase inhibition for ovarian cancer treatment
- (2016) Anselmo Papa et al. Journal of Translational Medicine
- Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial
- (2016) Jonathan A Ledermann et al. LANCET
- Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
- (2016) Ian J Jacobs et al. LANCET
- CCNE1 amplification and centrosome number abnormality in serous tubal intraepithelial carcinoma: further evidence supporting its role as a precursor of ovarian high-grade serous carcinoma
- (2016) Elisabetta Kuhn et al. MODERN PATHOLOGY
- Can advanced-stage ovarian cancer be cured?
- (2016) Steven Narod Nature Reviews Clinical Oncology
- Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer
- (2016) John K. Chan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
- (2016) Mansoor R. Mirza et al. NEW ENGLAND JOURNAL OF MEDICINE
- Integrative proteomic profiling of ovarian cancer cell lines reveals precursor cell associated proteins and functional status
- (2016) F. Coscia et al. Nature Communications
- TP53 mutations in epithelial ovarian cancer
- (2016) Yu Zhang et al. Translational Cancer Research
- Ovarian cancer
- (2016) Ursula A. Matulonis et al. Nature Reviews Disease Primers
- Inherited Mutations in Women With Ovarian Carcinoma
- (2016) Barbara M. Norquist et al. JAMA Oncology
- Incidental Serous Tubal Intraepithelial Carcinoma and Early Invasive Serous Carcinoma in the Nonprophylactic Setting
- (2015) Jane C. Morrison et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Cancers in Australia in 2010 attributable to modifiable factors: summary and conclusions
- (2015) David C. Whiteman et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH
- Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer
- (2015) Joan L. Walker et al. CANCER
- A phase 2 study of cediranib in recurrent or persistent ovarian, peritoneal or fallopian tube cancer: A trial of the Princess Margaret, Chicago and California Phase II Consortia
- (2015) H. Hirte et al. GYNECOLOGIC ONCOLOGY
- Beyond genomics: Critical evaluation of cell line utility for ovarian cancer research
- (2015) Kevin M. Elias et al. GYNECOLOGIC ONCOLOGY
- In vivo tumor growth of high-grade serous ovarian cancer cell lines
- (2015) Anirban K. Mitra et al. GYNECOLOGIC ONCOLOGY
- Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population
- (2015) Honglin Song et al. JOURNAL OF CLINICAL ONCOLOGY
- Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening
- (2015) Usha Menon et al. JOURNAL OF CLINICAL ONCOLOGY
- Does Aggressive Surgery Improve Outcomes? Interaction Between Preoperative Disease Burden and Complex Surgery in Patients With Advanced-Stage Ovarian Cancer: An Analysis of GOG 182
- (2015) Neil S. Horowitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer
- (2015) Susan J. Ramus et al. JNCI-Journal of the National Cancer Institute
- Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies
- (2015) LANCET
- Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial
- (2015) Sean Kehoe et al. LANCET
- Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial
- (2015) Amit M Oza et al. LANCET ONCOLOGY
- Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial
- (2015) Amit M Oza et al. LANCET ONCOLOGY
- Two drugs are better than one. A short history of combined therapy of ovarian cancer
- (2015) Barbara Bukowska et al. Wspolczesna Onkologia-Contemporary Oncology
- Survival of patients with structurally-grouped TP53 mutations in ovarian and breast cancers
- (2015) Brandon-Luke L. Seagle et al. Oncotarget
- Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer
- (2015) Susan J. Ramus et al. JNCI-Journal of the National Cancer Institute
- Using heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian cancer
- (2015) Zachary C. Dobbin et al. Oncotarget
- Germline Mutation in BRCA1 or BRCA2 and Ten-Year Survival for Women Diagnosed with Epithelial Ovarian Cancer
- (2014) Francisco J. Candido-dos-Reis et al. CLINICAL CANCER RESEARCH
- First-Line and Maintenance Therapy for Ovarian Cancer: Current Status and Future Directions
- (2014) Antonio González-Martín et al. DRUGS
- 3 Afuresertib (GSK2110183), an oral AKT kinase inhibitor, in combination with carboplatin and paclitaxel in recurrent ovarian cancer
- (2014) S. Blagden et al. EUROPEAN JOURNAL OF CANCER
- 2014 FIGO staging for ovarian, fallopian tube and peritoneal cancer
- (2014) David G. Mutch et al. GYNECOLOGIC ONCOLOGY
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- TP53 oncomorphic mutations predict resistance to platinum- and taxane-based standard chemotherapy in patients diagnosed with advanced serous ovarian carcinoma
- (2014) PAVLA BRACHOVA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
- (2014) Eric Pujade-Lauraine et al. JOURNAL OF CLINICAL ONCOLOGY
- Incorporation of Pazopanib in Maintenance Therapy of Ovarian Cancer
- (2014) Andreas du Bois et al. JOURNAL OF CLINICAL ONCOLOGY
- A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development
- (2014) Cheryl A Sherman-Baust et al. JOURNAL OF PATHOLOGY
- Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian Cancer
- (2014) Gottfried E. Konecny et al. JNCI-Journal of the National Cancer Institute
- Risk Prediction for Late-Stage Ovarian Cancer by Meta-analysis of 1525 Patient Samples
- (2014) Markus Riester et al. JNCI-Journal of the National Cancer Institute
- Ovarian cancer
- (2014) Gordon C Jayson et al. LANCET
- Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study
- (2014) Joyce F Liu et al. LANCET ONCOLOGY
- Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial
- (2014) Jonathan Ledermann et al. LANCET ONCOLOGY
- Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial
- (2014) Sandro Pignata et al. LANCET ONCOLOGY
- Ovarian Cancer Cell Line Panel (OCCP): Clinical Importance of In Vitro Morphological Subtypes
- (2014) Corine M. Beaufort et al. PLoS One
- In vivo multiplexed interrogation of amplified genes identifies GAB2 as an ovarian cancer oncogene
- (2014) G. P. Dunn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Integrated analysis of germline and somatic variants in ovarian cancer
- (2014) Krishna L. Kanchi et al. Nature Communications
- Clinical Characteristics of Ovarian Cancer Classified by BRCA1, BRCA2, and RAD51C Status
- (2014) J. M. Cunningham et al. Scientific Reports
- CDKN2D-WDFY2 Is a Cancer-Specific Fusion Gene Recurrent in High-Grade Serous Ovarian Carcinoma
- (2014) Kalpana Kannan et al. PLoS Genetics
- Breastfeeding and ovarian cancer risk: a meta-analysis of epidemiologic studies
- (2013) Nan-Nan Luan et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Transformation of the Fallopian Tube Secretory Epithelium Leads to High-Grade Serous Ovarian Cancer in Brca;Tp53;Pten Models
- (2013) Ruth Perets et al. CANCER CELL
- A Collagen-Remodeling Gene Signature Regulated by TGF-β Signaling Is Associated with Metastasis and Poor Survival in Serous Ovarian Cancer
- (2013) Dong-Joo Cheon et al. CLINICAL CANCER RESEARCH
- Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: A meta-analysis
- (2013) Suk-Joon Chang et al. GYNECOLOGIC ONCOLOGY
- Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies
- (2013) Weiva Sieh et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- The Stem-Cell Profile of Ovarian Surface Epithelium is Reproduced in the Oviductal Fimbriae, with Increased Stem-Cell Marker Density in Distal Parts of the Fimbriae
- (2013) Nelly Auersperg INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Epithelial ovarian cancer experimental models
- (2013) E Lengyel et al. ONCOGENE
- Evaluating cell lines as tumour models by comparison of genomic profiles
- (2013) Silvia Domcke et al. Nature Communications
- Impact of Complete Cytoreduction Leaving No Gross Residual Disease Associated with Radical Cytoreductive Surgical Procedures on Survival in Advanced Ovarian Cancer
- (2012) Suk-Joon Chang et al. ANNALS OF SURGICAL ONCOLOGY
- Derivation and characterization of matched cell lines from primary and recurrent serous ovarian cancer
- (2012) Isabelle J Létourneau et al. BMC CANCER
- The Changing View of High-Grade Serous Ovarian Cancer
- (2012) E. M. J. J. Berns et al. CANCER RESEARCH
- Age at menarche and risk of ovarian cancer: A meta-analysis of epidemiological studies
- (2012) Ting-Ting Gong et al. INTERNATIONAL JOURNAL OF CANCER
- Cancerous ovarian stem cells: Obscure targets for therapy but relevant to chemoresistance
- (2012) Nuzhat Ahmed et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Prognostically relevant gene signatures of high-grade serous ovarian carcinoma
- (2012) Roel G.W. Verhaak et al. JOURNAL OF CLINICAL INVESTIGATION
- OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- (2012) Carol Aghajanian et al. JOURNAL OF CLINICAL ONCOLOGY
- A DNA Repair Pathway–Focused Score for Prediction of Outcomes in Ovarian Cancer Treated With Platinum-Based Chemotherapy
- (2012) Josephine Kang et al. JNCI-Journal of the National Cancer Institute
- Assessment of symptomatic women for early diagnosis of ovarian cancer: results from the prospective DOvE pilot project
- (2012) Lucy Gilbert et al. LANCET ONCOLOGY
- Erratum: Integrated genomic analyses of ovarian carcinoma
- (2012) The Cancer Genome Atlas Research Network NATURE
- Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
- (2012) Jonathan Ledermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification of Quiescent, Stem-Like Cells in the Distal Female Reproductive Tract
- (2012) Yongyi Wang et al. PLoS One
- High-grade serous ovarian cancer arises from fallopian tube in a mouse model
- (2012) J. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- High frequency of allelic loss at the BRCA1 locus in ovarian cancers: clinicopathologic and molecular associations
- (2012) Iwona K. Rzepecka et al. Cancer Genetics
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Frequent genetic abnormalities of the PI3K/AKT pathway in primary ovarian cancer predict patient outcome
- (2011) Jia Huang et al. GENES CHROMOSOMES & CANCER
- Ovarian cancer linked to lynch syndrome typically presents as early-onset, non-serous epithelial tumors
- (2011) Zohreh Ketabi et al. GYNECOLOGIC ONCOLOGY
- Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigm
- (2011) Robert J. Kurman et al. HUMAN PATHOLOGY
- Phase II, Open-Label, Randomized, Multicenter Study Comparing the Efficacy and Safety of Olaparib, a Poly (ADP-Ribose) Polymerase Inhibitor, and Pegylated Liposomal Doxorubicin in Patients WithBRCA1orBRCA2Mutations and Recurrent Ovarian Cancer
- (2011) Stan B. Kaye et al. JOURNAL OF CLINICAL ONCOLOGY
- TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma-evidence supporting the clonal relationship of the two lesions
- (2011) Elisabetta Kuhn et al. JOURNAL OF PATHOLOGY
- Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study
- (2011) Karen A Gelmon et al. LANCET ONCOLOGY
- Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma
- (2011) Robert A Soslow et al. MODERN PATHOLOGY
- Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
- (2011) Kristin M Nieman et al. NATURE MEDICINE
- Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
- (2011) Robert A. Burger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ovarian Cancer Development and Metastasis
- (2010) Ernst Lengyel AMERICAN JOURNAL OF PATHOLOGY
- Shortened Telomeres in Serous Tubal Intraepithelial Carcinoma: An Early Event in Ovarian High-grade Serous Carcinogenesis
- (2010) Elisabetta Kuhn et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
- (2010) Robert J. Kurman et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses inBRCACarrier Ovarian Cancer Correlating With Platinum-Free Interval
- (2010) Peter C. Fong et al. JOURNAL OF CLINICAL ONCOLOGY
- Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial
- (2010) Gordon JS Rustin et al. LANCET
- HMGA2: A biomarker significantly overexpressed in high-grade ovarian serous carcinoma
- (2010) Aparna Mahajan et al. MODERN PATHOLOGY
- Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
- (2010) Ignace Vergote et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cystic and Adenofibromatous Clear Cell Carcinomas of the Ovary
- (2009) Emanuela Veras et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Exploratory analysis of serum CA-125 response to surgery and the risk of relapse in patients with FIGO stage IIIC ovarian cancer
- (2009) Oliver Zivanovic et al. GYNECOLOGIC ONCOLOGY
- Cediranib, an Oral Inhibitor of Vascular Endothelial Growth Factor Receptor Kinases, Is an Active Drug in Recurrent Epithelial Ovarian, Fallopian Tube, and Peritoneal Cancer
- (2009) Ursula A. Matulonis et al. JOURNAL OF CLINICAL ONCOLOGY
- Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
- (2008) R. W. Tothill et al. CLINICAL CANCER RESEARCH
- Antineoplastic agents in the management of ovarian cancer: current status and emerging therapeutic strategies
- (2008) Maurie Markman TRENDS IN PHARMACOLOGICAL SCIENCES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now